NCT01399684 / 2011-001867-28: A Study Evaluating the Efficacy and Safety of MEGF0444A Dosed to Progression in Combination With Bevacizumab and mFOLFOX-6 in Participants With Previously Untreated Metastatic Colorectal Cancer |
|
|
| Completed | 2 | 127 | US, Europe, RoW | 5-Fluorouracil, Bevacizumab, Folinic acid, MEGF0444A, Oxaliplatin, Placebo | Genentech, Inc. | Metastatic Colorectal Cancer | 02/14 | 02/14 | | |
